Modelling resilience in adolescence and adversity: a novel framework to inform research and practice

GS Malhi, P Das, E Bell, G Mattingly… - Translational psychiatry, 2019 - nature.com
Recent conceptualisations of resilience have advanced the notion that it is a dynamic and
multifaceted construct. However, its adaptive components, especially those forged by …

Dissociating normal aging from Alzheimer's disease: a view from cognitive neuroscience

M Toepper - Journal of Alzheimer's disease, 2017 - content.iospress.com
Both normal aging and Alzheimer's disease (AD) are associated with changes in cognition,
grey and white matter volume, white matter integrity, neural activation, functional …

Brain aging patterns in a large and diverse cohort of 49,482 individuals

Z Yang, J Wen, G Erus, ST Govindarajan, R Melhem… - Nature medicine, 2024 - nature.com
Brain aging process is influenced by various lifestyle, environmental and genetic factors, as
well as by age-related and often coexisting pathologies. Magnetic resonance imaging and …

High cerebrospinal amyloid-β 42 is associated with normal cognition in individuals with brain amyloidosis

A Sturchio, AK Dwivedi, CB Young, T Malm… - …, 2021 - thelancet.com
Background Brain amyloidosis does not invariably predict dementia. We hypothesized that
high soluble 42-amino acid β amyloid (Aβ42) peptide levels are associated with normal …

Multiplex cerebrospinal fluid proteomics identifies biomarkers for diagnosis and prediction of Alzheimer's disease

Y Guo, SD Chen, J You, SY Huang, YL Chen… - Nature human …, 2024 - nature.com
Recent expansion of proteomic coverage opens unparalleled avenues to unveil new
biomarkers of Alzheimer's disease (AD). Among 6,361 cerebrospinal fluid (CSF) proteins …

Association between anticholinergic medication use and cognition, brain metabolism, and brain atrophy in cognitively normal older adults

SL Risacher, BC McDonald, EF Tallman… - JAMA …, 2016 - jamanetwork.com
Importance The use of anticholinergic (AC) medication is linked to cognitive impairment and
an increased risk of dementia. To our knowledge, this is the first study to investigate the …

Association of altered liver enzymes with Alzheimer disease diagnosis, cognition, neuroimaging measures, and cerebrospinal fluid biomarkers

K Nho, A Kueider-Paisley, S Ahmad… - JAMA network …, 2019 - jamanetwork.com
Importance Increasing evidence suggests an important role of liver function in the
pathophysiology of Alzheimer disease (AD). The liver is a major metabolic hub; therefore …

Staging β-amyloid pathology with amyloid positron emission tomography

N Mattsson, S Palmqvist, E Stomrud, J Vogel… - JAMA …, 2019 - jamanetwork.com
Importance Different brain regions appear to be involved during β-amyloid (Aβ)
accumulation in Alzheimer disease (AD), but a longitudinally valid system to track Aβ stages …

A deep learning framework identifies dimensional representations of Alzheimer's Disease from brain structure

Z Yang, IM Nasrallah, H Shou, J Wen, J Doshi… - Nature …, 2021 - nature.com
Heterogeneity of brain diseases is a challenge for precision diagnosis/prognosis. We
describe and validate Smile-GAN (SeMI-supervised cLustEring-Generative Adversarial …

Sex differences in the association between AD biomarkers and cognitive decline

MEI Koran, M Wagener, TJ Hohman… - Brain imaging and …, 2017 - Springer
Women are disproportionately affected by Alzheimer's disease (AD) in terms of both disease
prevalence and severity. Previous autopsy work has suggested that, in the presence of AD …